Dall’11 al 14 ottobre 2022, ReiThera parteciperà al 29° Congresso ESGCT in collaborazione con la British Society for Gene & Cell Therapy nell’ International Conference Centre di Edimburgo. [...]
· GRAd-COV2 vaccine based on a recently developed group C gorilla adenoviral vector · Phase 2 trial confirms favorable safety profile for single and double dose regimens · [...]
